Low positivity rate after systematic screening for Trichomonas vaginalis in three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study

Sexually Transmitted Infections

Volumn 89, Issue 6, 2013, Pages 532-534

  Geelen, Tanja H ^a   Hoebe, Christian J P A ^a,b   Dirks, Anne ^a,b   Dukers Muijrers, Nicole H T M ^a,b   Van Bergen, Jan E A M ^c   Wolffs, Petra F G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Public Health Services   (Netherlands)

^c National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTITIONER; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; TRICHOMONIASIS;

CHLAMYDIA TRACHOMATIS; EPIDEMIOLOGY (CLINICAL); PCR; TRICHOMONAS;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; COINFECTION; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MASS SCREENING; NETHERLANDS; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; YOUNG ADULT;

EID: 84884505472     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-051010     Document Type: Article

References (12)

1. World Health Organization. Prevalence and incidence of selected sexually transmitted infections. 2011 http://www.who.int/reproductivehealth/publications/ rtis/9789241502450/en/ (accessed 17 May 2013).
2. Schirm J, Bos PA, Roozeboom-Roelfsema IK, et al. Trichomonas vaginalis detection using real-time TaqMan PCR. J Microbiol Methods 2007;68:243-7. (Pubitemid 46149933)
3. Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007;44:23-5. (Pubitemid 44968979)
4. Faber MT, Nielsen A, Nygard M, et al. Genital chlamydia, genital herpes, Trichomonas vaginalis and gonorrhea prevalence, and risk factors among nearly 70,000 randomly selected women in 4 Nordic countries. Sex Transm Dis 2011;38:727-34.
5. Munson E, Kramme T, Napierala M, et al. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection. J Clin Microbiol 2012;50:3927-31.
6. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-Age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26. (Pubitemid 351411908)
7. Dukers-Muijrers NH, van Liere GA, Hoebe CJ. Re-screening Chlamydia trachomatis positive subjects: a comparison of practices between an STI clinic, general practitioners and gynaecologists. Sex Transm Infect 2013;89:25-7.
8. van den Broek IV, van Bergen JE, Brouwers EE, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ 2012;345:e4316.
9. Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012;50:2601-8.
10. Munson KL, Napierala M, Munson E, et al. Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection. J Clin Microbiol 2013;51:101-4.
11. Schwebke JR, Lawing LF. Improved detection by DNA amplification of Trichomonas vaginalis in males. J Clin Microbiol 2002;40:3681-3.
12. Dize L, Agreda P, Quinn N, et al. Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis. Sex Transm Infect 2013;89:305-7.